Reply to "Concerns about the approach of measuring allergens in early introduction foods for prevention of food allergy"

Together, U.S. Food and Drug Administration (FDA) scientists have reported that these allergens (Ara h 1, Ara h 2, Ara h 3, Ara h 6) account for approximately 90% of peanut protein.4 The EIF with low doses of these proteins could reasonably be considered less effective in preventing peanut allergy....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The journal of allergy and clinical immunology in practice (Cambridge, MA) MA), 2021-07, Vol.9 (7), p.2945-2946
Hauptverfasser: Filep, Stephanie, Chapman, Martin D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Together, U.S. Food and Drug Administration (FDA) scientists have reported that these allergens (Ara h 1, Ara h 2, Ara h 3, Ara h 6) account for approximately 90% of peanut protein.4 The EIF with low doses of these proteins could reasonably be considered less effective in preventing peanut allergy. Preliminary data show a good correlation between allergen measurements, SDS-PAGE analyses, and mass spectrometry.7 Standardization of allergens, especially foods, is complex. The FDA categorizes food extracts in the United States as nonstandardized, with no valid potency measures.5 We are not aware whether the FDA has taken a position regarding EIF, other than that of a Qualified Health Claim.
ISSN:2213-2198
2213-2201
DOI:10.1016/j.jaip.2021.04.051